The data suggest that pathological activation of LNX1 and RhoC contributions to a lissencephaly phenotype may be the consequence of reduced LIS1 protein levels rather than missense-dependent disruption of LNX1-LIS1 specific binding. This evidence concerns the gene PAFAH1B1 and lissencephaly spectrum disorders.